Goldman Sachs Downgrades MAKO Surgical (MAKO) to Neutral

Article Stock Quotes (1) Comments (0)

Goldman Sachs downgraded MAKO Surgical (NASDAQ: MAKO) from Buy to Neutral with a price target of $17 (down from $36), following last night's second consecutive quarterly miss and lower guidance.

The firm comments, "Given slowing growth over the past two quarters, we are starting to question the long-term viability of MAKO's core technology and the extent to which the company can grow outside of its initial indication."


For an analyst ratings summary and ratings history on MAKO Surgical click here. For more ratings news on MAKO Surgical click here.

Shares of MAKO Surgical closed at $24.61 yesterday, with a 52 week range of $20.90-$45.15.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• UPDATE: Sterne Agee Downgrades Beazer Homes (BZH) to Neutral
• Macquarie Downgrades CME Group (CME) to Neutral
• Goldman Sachs Upgrades WNS (Holdings) (WNS) to Buy

Create E-mail Alert Related Categories

Downgrades, Hot Downgrades

Related Entities

Goldman Sachs

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?